SCHEMBL27628808

SCHEMBL27628808

CC(C)(C)OOC(=O)c1ccc(Cn2nnc(-c3cccc(I)c3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
HDAC6 Q9UBN7 5/20 0.48
THRB P10828 3/20 0.46
MMP13 P45452 3/20 0.46
TP53 P04637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
AOC3 Q16853 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4255014 0.90 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL4265054 0.81 SMN1; SMN2 (0.69) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL27628806 0.81 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL4266405 0.69 MMP13 (0.70) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL4262512 0.68 HDAC6 (0.44) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL4260422 0.68 MMP13 (0.68) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL4263436 0.68 MMP13 (0.78) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL4263261 0.67 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1LMNAHTTTDP1
SCHEMBL5512243 0.67 MAPK1 (0.46) SMN1; SMN2ALDH1A1LMNARAB9ANPC1
SCHEMBL4262856 0.67 MMP13 (0.71) SMN1; SMN2ALDH1A1LMNAHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100379415-C Hetero biaryl derivatives as matrix metalloproteinase inhibitors WARNER LAMBERT CO (US) 2008-04-09 CN disclosed
CN-1674892-A Hetero biaryl derivatives as matrix metalloproteinase inhibitors WARNER LAMBERT CO (US) 2005-09-28 CN disclosed